AEM vs IAUX

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

IAUX exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a lack of a viable Altman Z-Score. The company is fundamentally unstable, with negative gross margins (-1.01%) and a catastrophic profit margin of -208.89%, indicating it loses money on both a direct production and operational basis. While the stock has seen a speculative 1-year price surge of 144.2%, this is completely decoupled from its deteriorating fundamentals and negative revenue growth. Liquidity is a primary concern with a current ratio of 0.73, suggesting an inability to meet short-term obligations.